// App-Quantinova.ai

2171 : Serum IFN Score Predicts Long Term Outcome in Limited Cutaneous Systemic Sclerosis

Researchers

Presenter

  • Francesco Del Galdo

Principal Investigators

  • Ranjitha Karanth

  • Giuseppina Abignano

  • Vishal Kakkar

  • Rebecca Ross

  • Chris Denton

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Istituto Reumatologico Lucano (IReL), Azienda Ospedaliera Regionale San Carlo, Napoli, Italy

  • Kings College London, London, United Kingdom

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • C-X-C motif chemokine 10

  • C-X-C motif chemokine ligand 9

  • Chemokine (C-C motif) ligand 19

Drug/Treatment

  • Interferon

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A